Skip to main content
Transportation Update Actualización de transporte

SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.

Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.

Learn more

SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.

Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.

Obtenga más información AQUI

Age Restriction Updates for Evkeeza and Ajovy for Texas Medicaid and the CSHCN Services Program

Date: December 5, 2025

Attention: All Providers

Effective date: December 1, 2025

Call to action: Texas Children’s Health Plan (TCHP) informs providers that effective for dates of service on or after December 1, 2025:

  • Evinacumab-dgnb (Evkeeza) (procedure code J1305) will be a benefit for only Texas Medicaid clients who are 1 year of age or older.
  • Fremanezumab-vfrm (Ajovy) (procedure code J3031) will be a benefit for Texas Medicaid and Children with Special Health Care Needs (CSHCN) Services Program clients who are 6 years of age or older.

On December 1, 2025, the Texas Medicaid & Healthcare Partnership (TMHP) will update the Texas Medicaid Provider Procedures Manual (TMPPM), Outpatient Drug Services Handbook, sections 6.6, “Ajovy (Fremanezumab-vfrm),” and 6.51, “Evinacumab-dgnb (Evkeeza).”

Next steps: Providers should share this communication with their staff.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org

For access to all provider alerts: www.texaschildrenshealthplan.org/provideralerts.